Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| MYGN | Myriad Genetics | $4.11 | -$0.92 | -18.29% | 7.5M | $470M | $3.75$8.59 |
| COR | Cencora | $253.24 | -$52.66 | -17.21% | 460.1K | $60B | $244.82$377.54 |
Related Articles
Featured Article
3 Stocks to Buy as the Economy Recovers
David Jagielski, CPA|Oct 21, 2021
These companies have been delivering strong results, and investors should expect that to continue next year.
Report: States Pushing for $26.4 Billion Settlement With Drug Companies Over Opioid Liability
Eric Volkman|Aug 18, 2020
Producer Johnson & Johnson, and distributors McKesson, AmerisourceBergen, and Cardinal Health will all be expected to contribute to the settlement.
COVID-19 Pandemic Wreaks Havoc on Myriad Genetics' Fiscal Q4 Results
Keith Speights|Aug 14, 2020
But there were a few encouraging signs for the molecular-diagnostics company.
Got $1,000? Buy These 3 Medical Distributor Stocks
James Halley|Jun 5, 2020
These three companies dominate the industry, and all provide growth with a nice dividend.
Genetic Testing Stocks Rise Again as Volatility Continues
Maxx Chatsko|Mar 19, 2020
Have these growth stocks bottomed out? That's probably the wrong question to ask.
Should You Buy These 2 Prenatal Testing Stocks?
David Haen|Feb 29, 2020
More babies are born in summer and early fall than other times of year, meaning mothers-to-be are likely undergoing prenatal testing now. Can investors profit?
21 States Reject $18 Billion Bid to Settle Opioid Litigation
David Jagielski, CPA|Feb 14, 2020
The three big drug distributors have been in talks for months in the hopes of finding a global settlement.
Myriad Genetics CEO Mark Capone Resigns
Taylor Carmichael|Feb 7, 2020
The molecular diagnostics company also delivered an earnings miss, and its stock plunged.
Should You Own These 3 Healthcare Distributors?
David Haen|Dec 31, 2019
These medication movers touch most of the prescriptions in the U.S. Are their stocks a buy?
Why Shake Shack, Myriad Genetics, and Trivago Slumped Today
Dan Caplinger|Nov 5, 2019
Poor earnings took many stocks lower Tuesday.
